BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10426667)

  • 1. Oral etoposide for patients with advanced adenocarcinoma of the pancreas.
    Thomas E; Dumas P; Ajani JA
    Invest New Drugs; 1998-1999; 16(4):333-5. PubMed ID: 10426667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral etoposide for patients with metastatic gastric adenocarcinoma.
    Ajani JA; Mansfield PF; Dumas P
    Cancer J Sci Am; 1999; 5(2):112-4. PubMed ID: 10198733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of oral etoposide for patients with advanced breast cancer.
    Atienza DM; Vogel CL; Trock B; Swain SM
    Cancer; 1995 Dec; 76(12):2485-90. PubMed ID: 8625074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized phase I study of oral etoposide with or without granulocyte-macrophage colony-stimulating factor for the treatment of patients with advanced cancer.
    Weiss GR; Shaffer DW; DeMoor C; Rinaldi DA; Rodriguez GI; Eckardt JR; Stephens C; Von Hoff DD
    Anticancer Drugs; 1996 Jun; 7(4):402-9. PubMed ID: 8826608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged oral etoposide in recurrent or advanced non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
    Rose PG; Blessing JA; Buller RE; Mannel RS; Webster KD
    Gynecol Oncol; 2003 May; 89(2):267-70. PubMed ID: 12713990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily oral etoposide in metastatic breast cancer.
    Nesković-Konstantinović ZB; Bosnjak SM; Radulović SS; Mitrović LB
    Anticancer Drugs; 1996 Jul; 7(5):543-7. PubMed ID: 8862722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG; Blessing JA; Van Le L; Waggoner S
    Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study.
    Evans SR; Krown SE; Testa MA; Cooley TP; Von Roenn JH
    J Clin Oncol; 2002 Aug; 20(15):3236-41. PubMed ID: 12149296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etoposide (VP-16) in the treatment of advanced adenocarcinoma of the pancreas.
    Sternberg CN; Magill GB; Cheng EW; Applewhite A; Sordillo PP
    Am J Clin Oncol; 1988 Apr; 11(2):172-3. PubMed ID: 3282425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractionated doses of oral etoposide in the treatment of patients with aids-related kaposi sarcoma: a clinical and pharmacologic study to improve therapeutic index.
    Sprinz E; Caldas AP; Mans DR; Cancela A; DiLeone L; Dalla Costa T; Schwartsmann G
    Am J Clin Oncol; 2001 Apr; 24(2):177-84. PubMed ID: 11319295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group study.
    Poplin EA; Liu PY; Delmore JE; Wilczynski S; Moore DF; Potkul RK; Fine BA; Hannigan EV; Alberts DS
    Gynecol Oncol; 1999 Sep; 74(3):432-5. PubMed ID: 10479505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy.
    Schwartsmann G; Sprinz E; Kromfield M; Kalakun L; Sander E; Prolla G; Di Leone L; Gerhardt L; Mans DR
    J Clin Oncol; 1997 May; 15(5):2118-24. PubMed ID: 9164226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-day schedule oral etoposide therapy in advanced childhood malignancies.
    Schiavetti A; Varrasso G; Maurizi P; Cappelli C; Clerico A; Properzi E; Castello MA
    J Pediatr Hematol Oncol; 2000; 22(2):119-24. PubMed ID: 10779024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of Taxol in patients with advanced gastric carcinoma.
    Ajani JA; Fairweather J; Dumas P; Patt YZ; Pazdur R; Mansfield PF
    Cancer J Sci Am; 1998; 4(4):269-74. PubMed ID: 9689986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged oral etoposide in recurrent or advanced leiomyosarcoma of the uterus: a gynecologic oncology group study.
    Rose PG; Blessing JA; Soper JT; Barter JF
    Gynecol Oncol; 1998 Aug; 70(2):267-71. PubMed ID: 9740703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
    Kucuk O; Shevrin DH; Pandya KJ; Bonomi PD
    Am J Clin Oncol; 2000 Aug; 23(4):371-5. PubMed ID: 10955866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
    Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
    Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 21-day oral etoposide for metastatic breast cancer: a phase II study and review of the literature.
    Saphner T; Weller EA; Tormey DC; Pandya KJ; Falkson CI; Stewart J; Robert NJ
    Am J Clin Oncol; 2000 Jun; 23(3):258-62. PubMed ID: 10857889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.
    Rose PG; Blessing JA; Mayer AR; Homesley HD
    J Clin Oncol; 1998 Feb; 16(2):405-10. PubMed ID: 9469322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of 21 day schedule oral etoposide in children. New Agents Group of the United Kingdom Children's Cancer Study Group (UKCCSG).
    Davidson A; Gowing R; Lowis S; Newell D; Lewis I; Dicks-Mireaux C; Pinkerton CR
    Eur J Cancer; 1997 Oct; 33(11):1816-22. PubMed ID: 9470839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.